Representative flow cytometric plots of gated CD34+CD38− primary AML cells after the single or combination treatment with venetoclax and ATO are shown in Fig. 3a and Additional file 2: Fig. S1. The gene discussed is CD34; the disease is acute myeloid leukemia.